Cargando…
Protocol for characterizing the inhibition of SARS-CoV-2 infection by a protein of interest in cultured cells
Here, we present a protocol to characterize the antiviral ability of a protein of interest to SARS-CoV-2 infection in cultured cells, using MUC1 as an example. We use SARS-CoV-2 ΔN trVLP system, which utilizes transcription and replication-competent SARS-CoV-2 virus-like particles lacking nucleocaps...
Autores principales: | Lai, Xinyuan, Zhuang, Hui, Li, Tong, Xiang, Kuanhui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531662/ https://www.ncbi.nlm.nih.gov/pubmed/36345374 http://dx.doi.org/10.1016/j.xpro.2022.101802 |
Ejemplares similares
-
Identified human breast milk compositions effectively inhibit SARS-CoV-2 and variants infection and replication
por: Lai, Xinyuan, et al.
Publicado: (2022) -
Natural triterpenoids from licorice potently inhibit SARS-CoV-2 infection
por: Yi, Yang, et al.
Publicado: (2021) -
An antibody-based proximity labeling protocol to identify biotinylated interactors of SARS-CoV-2
por: Shang, Limin, et al.
Publicado: (2022) -
A tissue culture infectious dose-derived protocol for testing of SARS-CoV-2 neutralization of serum antibodies on adherent cells
por: Hasler, Fabio, et al.
Publicado: (2021) -
Protocol for production and purification of SARS-CoV-2 3CL(pro)
por: Mazzei, Luca, et al.
Publicado: (2023)